VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
REPL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
REPLReplimune Group, Inc.
$11.51$966M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksREPLQuarterly Financials

Replimune Group, Inc. (REPL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Replimune Group, Inc. (REPL) quarterly income statement — complete revenue, gross profit & net income history

REPL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold0000848K000000000000000
COGS % of Revenue--------------------
Gross Profit0000-848K000000000000000
Gross Margin %--------------------
Gross Profit Growth %100%-------------------
Operating Expenses73.34M71.87M84.29M90.42M79.03M66.02M58.92M57.37M58.76M56.54M63.83M55.65M52.99M41.63M41.58M40.88M31.99M29.7M29.25M27.38M
OpEx % of Revenue--------------------
Selling, General & Admin53.59M18.73M26.41M024.5M00000000012.74M11.4M010.35M9.35M8.83M
SG&A % of Revenue--------------------
Research & Development52.32M53.14M57.88M57.84M54.53M48M43.45M42.97M42.58M42.85M49.1M40.44M37.95M30.26M28.83M29.48M21.74M19.35M19.9M18.55M
R&D % of Revenue--------------------
Other Operating Expenses-1000K001000K01000K1000K1000K1000K1000K1000K1000K1000K1000K001000K000
Operating Income-73.34M-71.87M-84.29M-90.42M-79.88M-66.02M-58.92M-57.37M-58.76M-56.54M-63.83M-55.65M-52.99M-41.63M-41.58M-40.88M-31.99M-29.7M-29.25M-27.38M
Operating Margin %--------------------
Operating Income Growth %8.19%-8.86%-43.07%-57.62%-35.95%-16.77%7.7%-3.09%-10.87%-35.82%-53.52%-36.14%-65.67%-40.18%-42.16%-49.29%-44.19%-46.48%-48.74%-53.54%
EBITDA-76.1M-70.22M-83.75M-89.85M-79.03M-65.33M-57.99M-56.63M-55.62M-55.87M-63.18M-55.03M-52.47M-39.13M-40.96M-40.26M-31.44M-29.15M-28.71M-26.86M
EBITDA Margin %--------------------
EBITDA Growth %3.71%-7.49%-44.42%-58.66%-42.08%-16.94%8.21%-2.91%-6.02%-42.78%-54.23%-36.69%-66.89%-34.23%-42.65%-49.86%-44.95%-46.67%-49.26%-54.01%
D&A (Non-Cash Add-back)-2.76M1.65M542K573K848K693K925K736K3.13M675K654K621K528K2.5M617K620K549K548K532K518K
EBIT-72.31M-69.6M-82.58M-90M-72.8M-65.64M-58.51M-56.93M-58.09M-56.13M-63.39M-55.26M-52.11M-41.02M-42.55M-41.7M-31.06M-29.12M-28.8M-26.75M
Net Interest Income6.41M866K-518K-2M3.89M-1.98M-1.97M-1.96M-1.95M-1.55M-1.5M-1.66M-1.57M-1.49M-550K-552K-553K-555K-557K-558K
Interest Income10.78M2.85M005.88M000000000000000
Interest Expense4.37M1.98M518K2M1.99M1.98M1.97M1.96M1.95M1.55M1.5M1.66M1.57M1.49M550K552K553K555K557K558K
Other Income/Expense-119K627K1.19M3.73M5.09M254K5.86M3.6M3.62M5.89M3.59M6.29M4.04M1.94M-1.52M-1.38M292K24K-108K70K
Pretax Income-73.46M-71.24M-83.1M-86.69M-74.79M-65.77M-53.05M-53.77M-55.14M-50.65M-60.24M-49.35M-48.95M-39.69M-43.1M-42.25M-31.7M-29.67M-29.36M-27.31M
Pretax Margin %--------------------
Income Tax-240K-311K00-658K575K00-65K473K-201K201K288K0000000
Effective Tax Rate %0.33%0.44%0%0%0.88%-0.87%0%0%0.12%-0.93%0.33%-0.41%-0.59%0%0%0%0%0%0%0%
Net Income-73.22M-70.93M-83.1M-86.69M-74.13M-66.34M-53.05M-53.77M-55.08M-51.12M-60.04M-49.55M-49.24M-39.69M-43.1M-42.25M-31.7M-29.67M-29.36M-27.31M
Net Margin %--------------------
Net Income Growth %1.23%-6.92%-56.63%-61.22%-34.6%-29.77%11.64%-8.51%-11.85%-28.8%-39.31%-17.28%-55.35%-33.75%-46.83%-54.71%-47.43%-36.23%-46.08%-56.13%
Net Income (Continuing)-73.22M-70.93M-83.1M-86.69M-74.13M-66.34M-53.05M-53.77M-55.08M-51.12M-60.04M-49.55M-49.24M-39.69M-43.1M-42.25M-31.7M-29.67M-29.36M-27.31M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.76-0.77-0.90-0.95-0.96-0.79-0.68-0.78-0.90-0.77-0.90-0.75-0.87-0.69-0.79-0.78-0.67-0.57-0.56-0.53
EPS Growth %20.83%2.53%-32.35%-21.79%-6.67%-2.6%24.44%-4%-3.45%-11.59%-13.92%3.85%-29.85%-21.05%-41.07%-47.17%-45.65%-29.55%-21.74%-20.45%
EPS (Basic)-0.76-0.77-0.90-0.95-0.96-0.79-0.68-0.78-0.90-0.77-0.90-0.75-0.87-0.69-0.79-0.78-0.67-0.57-0.56-0.53
Diluted Shares Outstanding92.8M92.19M91.92M91.52M80.56M83.5M78.57M69.19M61.42M66.65M66.58M66.37M56.68M57.86M54.77M54.21M47.34M52.32M52.08M51.91M
Basic Shares Outstanding92.8M92.19M91.92M91.52M80.56M83.5M78.57M69.19M61.42M66.65M66.58M66.37M56.68M57.86M54.77M54.21M47.34M52.32M52.08M51.91M
Dividend Payout Ratio--------------------